E O Stapley1, J Birnbaum, A K Miller
1Merck Institute for Therapeutic Research, Rahway, New Jersey 07065.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Cefoxitin, a semisynthetic cephamycin antibiotic, shows high resistance to beta-lactamases and broad-spectrum activity, including against anaerobic pathogens like Bacteroides fragilis. Its effectiveness in experimental infections suggests it is a valuable agent for treating bacterial infections.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: